PMV Pharmaceuticals shares are trading higher. The company announced that NEJM publication highlighted the antitumor activity of rezatapopt in advanced solid tumor-types establishing proof-of-concept for p53 reactivation.

PMV Pharmaceuticals, Inc. -1.27%

PMV Pharmaceuticals, Inc.

PMVP

1.56

-1.27%

PMV Pharmaceuticals shares are trading higher. The company announced that NEJM publication highlighted the antitumor activity of rezatapopt in advanced solid tumor-types establishing proof-of-concept for p53 reactivation.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via